$8.77
−2.01%Price chart
Sep 30Oct 5Oct 8Oct 13Oct 16Oct 21Oct 26Oct 29
Key dataOct 29, 2026
Open$8.80
From 52W high−32.49%
Volume146654.00
Market cap$101.65M
P/E (TTM)—
P/S (TTM)31.2x
Div yield—
Key dataOct 29, 2026
Open
$8.80
From 52W high
−32.49%
Volume
146654.00
Market cap
$101.65M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.3x
P/E (TTM)
—
RSI (14)
44.7
MomentumView details →
1D Return
−2.01%
YTD Return
+24.90%
SummaryUpdated Jun 1, 2026
Predictive Oncology Inc. (NASDAQ:POAI) is a knowledge-driven biotechnology company founded in 2002 and headquartered in Eagan, Minnesota. Originally incorporated as Precision Therapeutics Inc., the company rebranded to its current name in June 2019 to better reflect its focus on artificial intelligence-driven cancer research. The company has evolved from a traditional medical device manufacturer into a science-driven organization that leverages artificial intelligence and machine learning to advance personalized cancer therapies and drug discovery processes.
Similar companies
Latest newsMore news →
Axe Compute Inc. signed Penguin Solutions, Inc. as a strategic partner to accelerate delivery of its next-generation AI infrastructure.16d agoDuos Technologies sold its GPU-as-a-Service entity to Axe Compute, removing approximately $98.1 million of prospective equipment financing as Duos shifts to a pure-play AI colocation platform.25d agoAxe Compute acquired full ownership of its Georgia AI cluster, extending its customer contract to five years and improving expected free cash flow and gross margin.25d ago